Table 1 Summary of the characteristics of studies and patients in 4 eligible RCTs.

From: Percutaneous transluminal angioplasty and stenting vs aggressive medical management on stroke or intracranial atherosclerotic stenosis: a systematic review and meta-analysis

Author yr

Group (n)

Ages, mean ± SD, yr

Gender, M/F

Hypertension, n

History of coronary artery disease, n

History of stroke (not qualifying event), n

Qualifying event, stroke/TIA

Smoker, never/former/current

Gao et al.9

PTAS (176)

56.7 ± 9.4

128/48

117

19

ND

89/87

96/39/41

AMM (182)

55.9 ± 9.8

135/47

125

19

ND

105/77

94/38/50

Miao et al.20

PTAS (36)

53.42 ± 13.55

24/12

23

3

ND

7/29

ND/ND/21

AMM (34)

49.18 ± 9.29

25/9

15

5

ND

8/26

ND/ND/19

Zaidat et al.19

PTAS (58)

61.8 ± 12.28

41/17

49

10

ND

36/24

25/22/11

AMM (53)

61.8 ± 12.82

32/21

43

12

ND

34/22

24/17/12

Derdeyn et al.15

PTAS (224)

61.0 ± 10.7

127/97

200

47

60

142/82

90/79/54

AMM (227)

59.5 ± 11.8

145/82

203

59

58

152/75

78/80/69

  1. PTAS percutaneous angioplasty and stenting, AMM aggressive medical management, RCT randomized control trial, ND not declared, M male, F female, IQR interquartile range, SD standard deviation, TIA transient ischemic attack, Yr year.
Back to article page